BioCryst Pharmaceuticals BCRX Capital investments accrued but not yet paid
Capital investments accrued but not yet paid at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CapitalExpendituresIncurredButNotYetPaid.
The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioCryst Pharmaceuticals's capital investments accrued but not yet paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioCryst Pharmaceuticals's capital investments accrued but not yet paid?
- BioCryst Pharmaceuticals (BCRX) reported capital investments accrued but not yet paid of $608K in Q1 2026.
- What does capital investments accrued but not yet paid mean?
- Reflects the value of capital assets acquired or projects initiated where the obligation has been recognized but the cash payment has not yet been disbursed. This provides visibility into committed capital spending that will impact future cash flows.